By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Bristol-Myers Squibb Company PFD CONV 2

Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)

OTC Currency in USD
$801.01
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$97.52B
Market Cap
27.59
P/E Ratio (TTM)
0.25%
Forward Dividend Yield
$735.50 - $1.23K
52 Week Range

BMYMP Stock Price Chart

Explore Bristol-Myers Squibb Company PFD CONV 2 interactive price chart. Choose custom timeframes to analyze BMYMP price movements and trends.

BMYMP Company Profile

Discover essential business fundamentals and corporate details for Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - General

IPO Date

8 Dec 2003

Employees

34.10K

CEO

Christopher S. Boerner

Description

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

BMYMP Financial Timeline

Browse a chronological timeline of Bristol-Myers Squibb Company PFD CONV 2 corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 29 Oct 2026

Upcoming earnings on 30 Jul 2026

Upcoming earnings on 30 Apr 2026

Upcoming earnings on 5 Feb 2026

Upcoming earnings on 30 Oct 2025

Earnings released on 31 Jul 2025

EPS came in at $0.64 falling short of the estimated $1.09 by -41.01%, while revenue for the quarter reached $12.27B , beating expectations by +7.21%.

Dividend declared on 17 Jun 2025

A dividend of $0.50 per share was announced, adjusted to $0.50. The dividend will be paid on 2 Sept 2025.

Earnings released on 24 Apr 2025

EPS came in at $18.63 surpassing the estimated $1.49 by +1.15K%, while revenue for the quarter reached $11.20B , beating expectations by +4.73%.

Dividend declared on 3 Mar 2025

A dividend of $0.50 per share was announced, adjusted to $0.50. The dividend was paid on 2 Jun 2025.

Earnings released on 6 Feb 2025

EPS came in at $0.55 , while revenue for the quarter reached $12.34B .

Dividend declared on 11 Dec 2024

A dividend of $0.50 per share was announced, adjusted to $0.50. The dividend was paid on 3 Mar 2025.

Earnings released on 31 Oct 2024

EPS came in at $9.17 , while revenue for the quarter reached $11.89B .

Earnings released on 26 Jul 2024

EPS came in at $12.74 , while revenue for the quarter reached $12.20B .

Earnings released on 25 Apr 2024

EPS came in at -$90.58 , while revenue for the quarter reached $11.87B .

Earnings released on 4 Mar 2024

EPS came in at $13.33 , while revenue for the quarter reached $11.48B .

Earnings released on 8 Jan 2024

EPS came in at $14.37 , while revenue for the quarter reached $10.97B .

Earnings released on 27 Jul 2023

EPS came in at $15.17 , while revenue for the quarter reached $11.23B .

Earnings released on 27 Apr 2023

EPS came in at $16.47 , while revenue for the quarter reached $11.34B .

Earnings released on 14 Feb 2023

EPS came in at $14.65 , while revenue for the quarter reached $11.41B .

Earnings released on 26 Oct 2022

EPS came in at $15.07 , while revenue for the quarter reached $11.22B .

Earnings released on 27 Jul 2022

EPS came in at $13.33 , while revenue for the quarter reached $11.89B .

Earnings released on 29 Apr 2022

EPS came in at $11.99 , while revenue for the quarter reached $11.65B .

Earnings released on 9 Feb 2022

EPS came in at $22.25 , while revenue for the quarter reached $11.99B .

Earnings released on 27 Oct 2021

EPS came in at $14.50 , while revenue for the quarter reached $11.62B .

Earnings released on 28 Jul 2021

EPS came in at $9.90 , while revenue for the quarter reached $11.70B .

Earnings released on 31 Mar 2021

EPS came in at $18.96 , while revenue for the quarter reached $11.07B .

Earnings released on 31 Dec 2020

EPS came in at -$94.07 , while revenue for the quarter reached $11.07B .

Earnings released on 30 Sept 2020

EPS came in at $17.56 , while revenue for the quarter reached $10.54B .

BMYMP Stock Performance

Access detailed BMYMP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run